AHR and neoplasm: By integrating our analysis with expression data from exposures to TCDD and expression data from pVHL-defective clear cell renal cell carcinoma (ccRCC), we provide insights into the potential repercussions of an impaired AHR pathway in ccRCC and its subsequent impact on tumour progression.